Pro-Life Americans Hope New FDA Leaders Will Finally Stop Mail-Order Abortions

Leadership changes continue at the U.S. Food and Drug Administration (FDA), with more high-level departures after FDA Commissioner Marty Makary’s exit. The effect of these changes remains to be seen, but pro-life advocates hope the personnel shake-up will also shake loose the stalled review of a Biden-era policy that removed critical safeguards around the use of mifepristone, the chemical abortion drug.At least three high-ranking FDA officials have departed since Makary’s sudden resignation last